{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:31:23Z","timestamp":1790872283770,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6,1]]},"DOI":"10.1097\/qai.0b013e318251aedd","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T19:49:24Z","timestamp":1331063364000},"page":"150-157","source":"Crossref","is-referenced-by-count":131,"title":["A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa"],"prefix":"10.1097","volume":"60","author":[{"given":"Anisa","family":"Mosam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmida","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Uldrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya","family":"Esterhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald H.","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Scadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamila","family":"Aboobaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoosen M.","family":"Coovadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R1-7-20210131","first-page":"S34","article-title":". Impact of potent antiretroviral therapy on the incidence of Kaposis sarcoma and non-Hodgkins lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.","volume":"21","author":"Jacobson","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R2-7-20210131","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1258\/ijsa.2008.008372","article-title":". Increasing incidence of Kaposis sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983-2006).","volume":"20","author":"Mosam","year":"2009","journal-title":"Int J STD AIDS"},{"issue":"3","key":"R3-7-20210131","first-page":"CD003256","article-title":"Treatment of Kaposis sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.","author":"Dedicoat","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-7-20210131","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00002030-200005260-00010","article-title":". Long-term efficacy on Kaposis sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre dinformation et de soins de limmunodeficience humaine.","volume":"14","author":"Dupont","year":"2000","journal-title":"AIDS"},{"key":"R5-7-20210131","first-page":"779","article-title":". Long-term clinical outcome of AIDS-related Kaposis sarcoma during highly active antiretroviral therapy.","volume":"27","author":"Cattelan","year":"2005","journal-title":"Int J Oncol"},{"key":"R6-7-20210131","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00126334-200212010-00003","article-title":". Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma-associated herpesvirus infection in patients with and without Kaposi sarcoma.","volume":"31","author":"Gill","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-7-20210131","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/01.aids.0000131385.60974.b9","article-title":". Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposis sarcoma.","volume":"18","author":"Martin-Carbonero","year":"2004","journal-title":"AIDS"},{"key":"R8-7-20210131","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1002\/cncr.25362","article-title":". Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.","volume":"116","author":"Cianfrocca","year":"2010","journal-title":"Cancer"},{"key":"R9-7-20210131","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1008367822016","article-title":". Essential drugs for cancer therapy: a World Health Organization consultation.","volume":"10","author":"Sikora","year":"1999","journal-title":"Ann Oncol"},{"key":"R10-7-20210131","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ijc.20606","article-title":". Treatment of AIDS-associated Kaposis sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial.","volume":"113","author":"Olweny","year":"2005","journal-title":"Int J Cancer"},{"key":"R11-7-20210131","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1258\/ijsa.2009.009145","article-title":". An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposis sarcoma in KwaZulu-Natal, South Africa.","volume":"22","author":"Mosam","year":"2011","journal-title":"Int J STD AIDS"},{"key":"R12-7-20210131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.qai.0000164033.02947.e3","article-title":". Survival after cancer diagnosis in persons with AIDS.","volume":"39","author":"Biggar","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-7-20210131","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposis sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"key":"R14-7-20210131","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","article-title":"AIDS-related Kaposis sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.","volume":"15","author":"Krown","year":"1997","journal-title":"J Clin Oncol"},{"key":"R15-7-20210131","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(91)80081-V","article-title":". Systemic treatment of AIDS-related Kaposis sarcoma: results of a randomized trial.","volume":"90","author":"Gill","year":"1991","journal-title":"Am J Med"},{"key":"R16-7-20210131","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1200\/JCO.2002.12.038","article-title":". Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposis sarcoma: an AIDS Clinical Trials Group clinical study.","volume":"20","author":"Evans","year":"2002","journal-title":"J Clin Oncol"},{"key":"R17-7-20210131","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/339074","article-title":". The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.","volume":"34","author":"Mannheimer","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"2","key":"R18-7-20210131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09540120701534699","article-title":". A randomized comparison of two instruments for measuring self-reported antiretroviral adherence.","volume":"20","author":"Mannheimer","year":"2008","journal-title":"AIDS Care"},{"key":"R19-7-20210131","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-642-84745-5_28","article-title":"Assessment of quality of life and benefits from adjuvant therapies in breast cancer.","volume":"127","author":"Aaronson","year":"1993","journal-title":"Recent Results Cancer Res"},{"key":"R20-7-20210131","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":". The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R21-7-20210131","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/589865","article-title":". Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.","volume":"47","author":"Martin-Carbonero","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R22-7-20210131","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/jnci\/djq134","article-title":". Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.","volume":"102","author":"Lodi","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R23-7-20210131","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/QAI.0b013e3181bc476f","article-title":". Predictors of immune reconstitution inflammatory syndrome-associated with Kaposi sarcoma in mozambique: a prospective study.","volume":"53","author":"Letang","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-7-20210131","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/654798","article-title":". An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.","volume":"51","author":"Uldrick","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R25-7-20210131","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1258\/ijsa.2008.007301","article-title":". Characteristics of HIV-1-associated Kaposis sarcoma among women and men in South Africa.","volume":"19","author":"Mosam","year":"2008","journal-title":"Int J STD AIDS"},{"key":"R26-7-20210131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00042560-199904010-00003","article-title":". AIDS-associated Kaposis sarcoma is more aggressive in women: a study of 54 patients.","volume":"20","author":"Nasti","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R27-7-20210131","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/QAI.0b013e31802c83d9","article-title":". Gender differences in AIDS-associated Kaposi sarcoma in Harare, Zimbabwe.","volume":"44","author":"Meditz","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-7-20210131","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.bjc.6603056","article-title":". Remission from Kaposis sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.","volume":"94","author":"Martinez","year":"2006","journal-title":"Br J Cancer"},{"key":"R29-7-20210131","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/QAD.0b013e328182df03","article-title":". Kaposis sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAARTchemotherapy in HIV clade C-infected individuals with Kaposis sarcoma.","volume":"21","author":"Bihl","year":"2007","journal-title":"AIDS"},{"key":"R30-7-20210131","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/QAD.0b013e32832d080d","article-title":". The effect of HAART in 254 consecutive patients with AIDS-related Kaposis sarcoma.","volume":"23","author":"Bower","year":"2009","journal-title":"AIDS"},{"key":"R31-7-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2004.08.064","article-title":"Highly active antiretroviral therapy in AIDS-associated Kaposis sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposis sarcoma.","volume":"22","author":"Krown","year":"2004","journal-title":"J Clin Oncol"},{"key":"R32-7-20210131","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/QAD.0b013e3282ff6275","article-title":". Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.","volume":"22","author":"Nguyen","year":"2008","journal-title":"AIDS"},{"key":"R33-7-20210131","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AAC.01295-10","article-title":". The HIV protease inhibitor nelfinavir inhibits Kaposis sarcoma-associated herpesvirus replication in vitro.","volume":"55","author":"Gantt","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R34-7-20210131","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1182\/blood-2010-11-317610","article-title":". High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.","volume":"117","author":"Uldrick","year":"2011","journal-title":"Blood"},{"key":"R35-7-20210131","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1081\/CNV-100104284","article-title":". Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposis sarcoma: a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine.","volume":"19","author":"Osoba","year":"2001","journal-title":"Cancer Invest"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201206010-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:41:31Z","timestamp":1786048891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201206010-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,1]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318251aedd","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,1]]}}}